3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Interventions
Cyclophosphamide
170
Rituximab
143
Specimen Handling
83
venetoclax
78
fludarabine
78
Vincristine
69
obinutuzumab
66
Doxorubicin
66
Prednisone
65
Biopsy
64
Magnetic Resonance Spectroscopy
63
zanubrutinib
52
Lenalidomide
52
Dexamethasone
49
Methotrexate
43
Cytarabine
43
blinatumomab
40
Immunotherapy, Adoptive
37
Bendamustine Hydrochloride
37
acalabrutinib
36
Etoposide
32
fludarabine phosphate
31
ibrutinib
28
glofitamab
28
polatuzumab vedotin
26
pirtobrutinib
24
orelabrutinib
24
Gemcitabine
23
Injections
21
Mercaptopurine
19
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
AIEOP acute lymphoblastic leukemia protocol
×
Lymphoid
×
Clear all
NCT06184009
2025-06-08
HR ALL
Seoul St. Mary's Hospital
Phase 2
Recruiting
370 enrolled